B. S. Pessôa

Angiotensin II Type 2 Receptor– and Acetylcholine-Mediated RelaxationNovelty and Significance

S. Kushner, A. Grefhorst, D. E. Slump, 2015 .

Angiotensin II type 2 receptor- and acetylcholine-mediated relaxation: essential contribution of female sex hormones and chromosomes.

S. Kushner, A. Grefhorst, D. E. Slump, 2015, Hypertension.

The Alternative Renin-Angiotensin System: exploration of its therapeutic potential

B. S. Pessôa, 2015 .

Key developments in renin–angiotensin–aldosterone system inhibition

E. Hoorn, Nils van der Lubbe, A. Danser, 2013, Nature Reviews Nephrology.

Multiple Ascending Dose Study With the New Renin Inhibitor VTP-27999: Nephrocentric Consequences of Too Much Renin Inhibition

J. Ménard, R. Reeves, M. Azizi, 2014, Hypertension.

Antioxidant SOD Mimetic Prevents NADPH Oxidase-Induced Oxidative Stress and Renal Damage in the Early Stage of Experimental Diabetes and Hypertension

B. S. Pessôa, J. B. Lopes de Faria, S. Biswas, 2008, American Journal of Nephrology.

Effect of a Stable Angiotensin‐(1–7) Analogue on Progenitor Cell Recruitment and Cardiovascular Function Post Myocardial Infarction

V. V. D. van der Velden, H. V. van Beusekom, D. Westermann, 2015, Journal of the American Heart Association.

Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat

B. S. Pessôa, J. B. Lopes de Faria, J. M. Lopes de Faria, 2012, Journal of the renin-angiotensin-aldosterone system : JRAAS.